Drug Information
Drug (ID: DG01809) and It's Reported Resistant Information
| Name |
Succinate
|
||||
|---|---|---|---|---|---|
| Synonyms |
Succinate; Butanedioate; Succinate dianion; Butanedioic acid, ion(2-); 56-14-4; UNII-AJ326AG789; AJ326AG789; succ; monosuccinate; Butanedioate(2-); Succinate ion; succinate(2-); Succinate ion(2-); suc; Succinic acid, ion(2-); DTXSID4036772; CHEBI:30031; ANION STANDARD - SUCCINATE; STL302037; (-)OOC-CH2-CH2-COO(-); AKOS022140212; A802155; Q27104100
Click to Show/Hide
|
||||
| Structure |
|
||||
| Drug Resistance Disease(s) |
Disease(s) with Clinically Reported Resistance for This Drug
(1 diseases)
[1]
|
||||
| Target | . | NOUNIPROTAC | [1] | ||
| Click to Show/Hide the Molecular Information and External Link(s) of This Drug | |||||
| Formula |
1
|
||||
| IsoSMILES |
C(CC(=O)[O-])C(=O)[O-]
|
||||
| InChI |
InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)/p-2
|
||||
| InChIKey |
KDYFGRWQOYBRFD-UHFFFAOYSA-L
|
||||
| PubChem CID | |||||
| INTEDE ID | |||||
Type(s) of Resistant Mechanism of This Drug
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Key Molecule: Maternally expressed 3 (MEG3) | [1] | |||
| Molecule Alteration | . | Expression |
||
| Resistant Disease | Oral squamous cell carcinoma [ICD-11: 2B6E.0] | |||
| Experimental Note | Identified from the Human Clinical Data | |||
| In Vitro Model | CAL-27 cells | Tongue | Homo sapiens (Human) | CVCL_1107 |
| OLP type I keratinocytes | N.A. | . | N.A. | |
| Experiment for Drug Resistance |
Cell Titer-Glo assay; IC50 assay | |||
| Mechanism Description | The critical roles of succinate and MEG3 in the metabolic changes during malignant transformation from OLP to OSCC. | |||
References
visits since 2022
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.
